98 related articles for article (PubMed ID: 18085509)
21. Folding of beta-sheet membrane proteins: a hydrophobic hexapeptide model.
Wimley WC; Hristova K; Ladokhin AS; Silvestro L; Axelsen PH; White SH
J Mol Biol; 1998 Apr; 277(5):1091-110. PubMed ID: 9571025
[TBL] [Abstract][Full Text] [Related]
22. The role of the central L- or D-Pro residue on structure and mode of action of a cell-selective alpha-helical IsCT-derived antimicrobial peptide.
Lim SS; Kim Y; Park Y; Kim JI; Park IS; Hahm KS; Shin SY
Biochem Biophys Res Commun; 2005 Sep; 334(4):1329-35. PubMed ID: 16040002
[TBL] [Abstract][Full Text] [Related]
23. Solid-state nuclear magnetic resonance relaxation studies of the interaction mechanism of antimicrobial peptides with phospholipid bilayer membranes.
Lu JX; Damodaran K; Blazyk J; Lorigan GA
Biochemistry; 2005 Aug; 44(30):10208-17. PubMed ID: 16042398
[TBL] [Abstract][Full Text] [Related]
24. Methods for assessing the structure and function of cationic antimicrobial peptides.
Pate M; Blazyk J
Methods Mol Med; 2008; 142():155-73. PubMed ID: 18437313
[TBL] [Abstract][Full Text] [Related]
25. Effect of cholesterol on the membrane interaction of Modelin-5 isoforms.
Dennison SR; Phoenix DA
Biochemistry; 2011 Dec; 50(50):10898-909. PubMed ID: 22082130
[TBL] [Abstract][Full Text] [Related]
26. A novel beta-defensin structure: big defensin changes its N-terminal structure to associate with the target membrane.
Kouno T; Mizuguchi M; Aizawa T; Shinoda H; Demura M; Kawabata S; Kawano K
Biochemistry; 2009 Aug; 48(32):7629-35. PubMed ID: 19588912
[TBL] [Abstract][Full Text] [Related]
27. Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains.
Lockwood NA; Haseman JR; Tirrell MV; Mayo KH
Biochem J; 2004 Feb; 378(Pt 1):93-103. PubMed ID: 14609430
[TBL] [Abstract][Full Text] [Related]
28. Interactions of amphipathic CPPs with model membranes.
Deshayes S; Konate K; Aldrian G; Heitz F; Divita G
Methods Mol Biol; 2011; 683():41-56. PubMed ID: 21053121
[TBL] [Abstract][Full Text] [Related]
29. Defensins promote fusion and lysis of negatively charged membranes.
Fujii G; Selsted ME; Eisenberg D
Protein Sci; 1993 Aug; 2(8):1301-12. PubMed ID: 8401215
[TBL] [Abstract][Full Text] [Related]
30. Effects on antigen-presenting cells of short-term interaction with the human host defence peptide β-defensin 2.
Morgera F; Pacor S; Creatti L; Antcheva N; Vaccari L; Tossi A
Biochem J; 2011 Jun; 436(3):537-46. PubMed ID: 21434867
[TBL] [Abstract][Full Text] [Related]
31. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.
Tsai CW; Hsu NY; Wang CH; Lu CY; Chang Y; Tsai HH; Ruaan RC
J Mol Biol; 2009 Sep; 392(3):837-54. PubMed ID: 19576903
[TBL] [Abstract][Full Text] [Related]
32. The novel antimicrobial peptide beta3-defensin is produced by the amnion: a possible role of the fetal membranes in innate immunity of the amniotic cavity.
Buhimschi IA; Jabr M; Buhimschi CS; Petkova AP; Weiner CP; Saed GM
Am J Obstet Gynecol; 2004 Nov; 191(5):1678-87. PubMed ID: 15547542
[TBL] [Abstract][Full Text] [Related]
33. The conformational analysis of peptides using Fourier transform IR spectroscopy.
Haris PI; Chapman D
Biopolymers; 1995; 37(4):251-63. PubMed ID: 7540054
[TBL] [Abstract][Full Text] [Related]
34. Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.
Patil AA; Cai Y; Sang Y; Blecha F; Zhang G
Physiol Genomics; 2005 Sep; 23(1):5-17. PubMed ID: 16033865
[TBL] [Abstract][Full Text] [Related]
35. Study of the interaction of human defensins with cell membrane models: relationships between structure and biological activity.
Lourenzoni MR; Namba AM; Caseli L; Degrève L; Zaniquelli ME
J Phys Chem B; 2007 Sep; 111(38):11318-29. PubMed ID: 17784741
[TBL] [Abstract][Full Text] [Related]
36. Synthetic peptides corresponding to the beta-hairpin loop of rabbit defensin NP-2 show antimicrobial activity.
Thennarasu S; Nagaraj R
Biochem Biophys Res Commun; 1999 Jan; 254(2):281-3. PubMed ID: 9918829
[TBL] [Abstract][Full Text] [Related]
37. Identification of structural traits that increase the antimicrobial activity of a chimeric peptide of human β-defensins 2 and 3.
Spudy B; Sönnichsen FD; Waetzig GH; Grötzinger J; Jung S
Biochem Biophys Res Commun; 2012 Oct; 427(1):207-11. PubMed ID: 22995312
[TBL] [Abstract][Full Text] [Related]
38. Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes?
Papo N; Shai Y
Peptides; 2003 Nov; 24(11):1693-703. PubMed ID: 15019200
[TBL] [Abstract][Full Text] [Related]
39. A new bioproduction route for a novel antimicrobial peptide.
Tay DK; Rajagopalan G; Li X; Chen Y; Lua LH; Leong SS
Biotechnol Bioeng; 2011 Mar; 108(3):572-81. PubMed ID: 20967800
[TBL] [Abstract][Full Text] [Related]
40. Interaction of human β-defensin 2 (HBD2) with glycosaminoglycans.
Seo ES; Blaum BS; Vargues T; De Cecco M; Deakin JA; Lyon M; Barran PE; Campopiano DJ; Uhrín D
Biochemistry; 2010 Dec; 49(49):10486-95. PubMed ID: 21062008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
